Abstract:9-Nitrocamptothecin (9-NC) is an orally administered topoisomerase-I inhibitor for the treatment of pancreatic carcinoma, but its oral absorption and bioavailability are poor. The main objective of this study was to develop optimal 9-nitrocamptothecin (9-NC) microemulsion prepared by self-microemulsifying drug delivery system (SMEDDS). Two SMEDDS formulations of 9-NC prepared from a mixture of ethyl oleate, Tween-80 (T-form) or Cremophor EL (C-form), and PEG-400/ethanol were formed as microemulsions under dilution with aqueous phase. The resulting microemulsions were evaluated in vitro and in vivo, including the kinetics and antitumor effects in SKOV-3 human ovarian cancer xenograft in nude mice. Following 1:10 aqueous dilution of optimal 9-NC SMEDDS, the droplet sizes of resulting microemulsions were (30.8±4.6)nm and (39.8±8.2)nm for SMEDDS T-form and C-form, respectively, and the zeta potential values were −(4.3±0.5)mV and −(5.7±0.5)mV, respectively. In SKOV-3 cells, the growth inhibition (IC50) of various 9-NC formulations was greatest with SMEDDS T-form (3.5±0.7nM) followed by SMEDDS C-form (4.6±0.4nM), 9-NC solution (6.6±1.4nM) and 9-NC suspension (26.0±2.9nM) (P<0.01). It was indicated that the area under the plasma concentration–time curve (AUC0→8h) values of various formulations of 9-NC after oral administration ranked as the following sequence: SMEDDS T-form (360.12±19.44ngh/ml)≈SMEDDS C-form (351.71±33.66ngh/ml)>9-NC solution (241.21±24.67ngh/ml)>9-NC suspension (161.24±24.31ngh/ml). The 9-NC SMEDDS formulations also produced significantly more tumor shrinkage (P<0.01) when compared to 9-NC suspension in nude mice bearing human ovarian cancer xenografts. The results suggest that SMEDDS is a promising drug delivery system to increase the oral bioavailability and antitumor effects of 9-NC and may be applied to other lipophilic drugs. 9-NC SMEDDS represents a novel 9-NC therapy for cancer patients.

Preparation of 9-Nitrocamptothecin Self-Emulsification Microemulsion and in Vitro Cytotoxicity Evaluation

Preparation of 9-Nitrocamptothecin Self-Emulsified Microemulsion and Its Pharmacokinetics in Rats

Self-microemulsifying Drug Delivery System (SMEDDS) Improves Anticancer Effect of Oral 9-Nitrocamptothecin on Human Cancer Xenografts in Nude Mice.

Protection Effect of Self-Emulsifying Microemulsion on 9-Nitrocamptothecin Lactone Form

Study on the Protection of Self-Emulsification Microemulsion Tolactone Structure of 9-Nitrocamptothecin

Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery.

Preparation and Characterization of 9-Nitrocamptothecin Incorporated in Egg Phasphatidyl-Cboline-sodium Deoxycholate Mixed Micelles

Novel Polymeric Micelles with Cinnamic Acid As Lipophilic Moiety for 9-Nitro-20(s)-camptothecin Delivery

Soluplus® Based 9-Nitrocamptothecin Solid Dispersion for Peroral Administration: Preparation, Characterization, in Vitro and in Vivo Evaluation

Investigations on Preparation and Release Behavior in Vitro of 9-Nitro Camptothecin Encapsulated Micelles

Preparation of 9-Nitrocamptothecin Liposome and Its Pharmacokinetic after Pulmonary Delivery to Rats

Distribution of 9-nitro-20(S)-camptothecin loaded micelles in the blood and organs of rats

Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.

Complex of 9-nitro-camptothecin in hydroxypropyl-β-cyclodextrin: In vitro and in vivo evaluation

A Submicron Emulsion for Intravenous Injection of 7-Ethyl-10-Hydroxycamptothecin: Characterization, Pharmacolcinetic and Biodistribution Studies, In Vitro and In Vivo Antitumor Effect

A Process for Preparation of Anticancer Drug 9-Nitro Camptothecin

Study on Nimodipine Self-microemulsifying Drug Delivery System

Biodistribution in Mice and Severity of Damage in Rat Lungs Following Pulmonary Delivery of 9-Nitrocamptothecin Liposomes

9-Nc-loaded Folate-Conjugated Polymer Micelles As Tumor Targeted Drug Delivery System: Preparation and Evaluation in Vitro.

Ph-Gradient Incorporation of 9-Nitrocamptothecin in PEGylated Liposomes: Formulation Properties and Efficacy in Vitro and in Vivo

[9-Nitrocamptothecin Nanostructured Lipid Carrier System: in Vitro Releasing Characteristics, Uptake by Cells, and Tissue Distribution in Vivo].